Johansen JS - Search Results

1

Plasma YKL-40: a potential new cancer biomarker?

Johansen JS, Schultz NA, Jensen BV. Johansen JS, et al. Future Oncol. 2009 Sep;5(7):1065-82. doi: 10.2217/fon.09.66. Future Oncol. 2009. PMID: 19792974 Review.

2

Extracellular matrix building marked by the N-terminal propeptide of procollagen type I reflect aggressiveness of recurrent breast cancer.

Jensen BV, Johansen JS, Skovsgaard T, Brandt J, Teisner B. Jensen BV, et al. Among authors: johansen js. Int J Cancer. 2002 Apr 1;98(4):582-9. doi: 10.1002/ijc.10187. Int J Cancer. 2002. PMID: 11920619 Free article.

3

Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease.

Kronborg G, Ostergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, Price PA, Johansen JS. Kronborg G, et al. Among authors: johansen js. Scand J Infect Dis. 2002;34(5):323-6. doi: 10.1080/00365540110080233. Scand J Infect Dis. 2002. PMID: 12069012

4

High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival.

Cintin C, Johansen JS, Christensen IJ, Price PA, Sørensen S, Nielsen HJ. Cintin C, et al. Among authors: johansen js. Cancer. 2002 Jul 15;95(2):267-74. doi: 10.1002/cncr.10644. Cancer. 2002. PMID: 12124825 Free article.

5

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.

Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: johansen js. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127 Free article.

6

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U; EMALD Group. Nøjgaard C, et al. Among authors: johansen js. J Hepatol. 2003 Aug;39(2):179-86. doi: 10.1016/s0168-8278(03)00184-3. J Hepatol. 2003. PMID: 12873813

7

High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.

Høgdall EV, Johansen JS, Kjaer SK, Price PA, Christensen L, Blaakaer J, Bock JE, Glud E, Høgdall CK. Høgdall EV, et al. Among authors: johansen js. Oncol Rep. 2003 Sep-Oct;10(5):1535-8. Oncol Rep. 2003. PMID: 12883737

8

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival.

Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. Johansen JS, et al. Breast Cancer Res Treat. 2003 Jul;80(1):15-21. doi: 10.1023/A:1024431000710. Breast Cancer Res Treat. 2003. PMID: 12889595

9

High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.

Jensen BV, Johansen JS, Price PA. Jensen BV, et al. Among authors: johansen js. Clin Cancer Res. 2003 Oct 1;9(12):4423-34. Clin Cancer Res. 2003. PMID: 14555515

10

High serum YKL-40 level in patients with small cell lung cancer is related to early death.

Johansen JS, Drivsholm L, Price PA, Christensen IJ. Johansen JS, et al. Lung Cancer. 2004 Dec;46(3):333-40. doi: 10.1016/j.lungcan.2004.05.010. Lung Cancer. 2004. PMID: 15541818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page